Skip to main content
OpenTrials
Completed

NCT Number: NCT00131690

Effect of Caffeine on Fetal Growth

The purpose of this study is to determine whether caffeine has any effect on birth weight.

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Danish Epidemiology Science Centre

Vennelyst Boulevard 6, Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant
  • Consumption of at least 3 cups of coffee/day at recruitment

Exclusion criteria

  • Gestational age more than 20 weeks at recruitment
  • Chronic kidney disease
  • Epilepsy
  • Insulin dependent diabetes
  • Metabolic disorder
  • Previous low birth weight delivery
  • Previous preterm delivery

Treatment and study plan

Nescafé Gold Blend (exposed)

Drug

Nescafé Decaffeinated (controls)

Drug

Primary outcomes

  1. birth weight

  2. gestational age

Sponsors and collaborators

Lead sponsor

The Danish Epdiemiology Science Centre

Other

Registry information

Official study title

The Importance of Caffeine in Fetal Growth

Important dates

Study start
1996
Study completion
2002
First posted
Aug 19, 2005
Registry last updated
Oct 10, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.